Sign in
R&D
Clinical
Commercial
Brand & Marketing
Technology
Insights
Podcast
Awards
Rising Stars Award 2025 Nominations
Winners of LSV Top Industry Leaders Award 2024
List of Winners of the Rising Stars Award 2024
More
Manufacturing
Regulatory
Editorial
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Privacy Policy
Password recovery
Recover your password
your email
Search
LifeNews
Life Science
Fashion Trends and Culture
R&D
Research & Development
Scientists Identify New Target to Prevent Cancer from Spreading to Bones
May 22, 2025
Research & Development
New Data Positions Immutep’s Immunotherapy Combo as First-Line Option for PD-L1-Negative HNSCC
May 7, 2025
Research & Development
BioMed X Launches XBridge Program to Support U.S. Reacsearchers Amid NIH Funding Cuts
April 8, 2025
Research & Development
Taiho spends $400 million with a Swiss partner to “turbocharge” three ADCs to the clinic
March 20, 2025
Clinical
Clinical
4DMT Accelerates Phase 3 Eye Gene Therapy Trials Despite 25% Workforce Reduction
July 7, 2025
Clinical
Bezuclastinib Meets Primary Endpoint in Phase 3 Trial for Systemic Mastocytosis
July 7, 2025
Clinical
Cosentyx Misses Primary Endpoint in Phase III Giant Cell Arteritis Trial
July 4, 2025
Clinical
Organon Says Goodbye to Endometriosis Drug Candidate After Phase 2 Failure
July 4, 2025
Commercial
All
Brand & Marketing
Commercial
AstraZeneca’s Alexion Signs $825 Million Gene Therapy Licensing Deal with JCR Pharmaceuticals
July 11, 2025
Commercial
Shionogi Acquires Rights to BioVersys’ BV500 Program Targeting NTM Infections
July 4, 2025
Commercial
Argenx and Unnatural Products Sign $1.5 Billion Deal to Develop Macrocyclic Peptide Therapies
July 2, 2025
Technology
Technology
Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI
July 7, 2025
Technology
J&J MedTech presents the first Ottava surgical robot clinical cases
April 17, 2025
Commercial
Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances
October 23, 2024
Technology
PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm
September 26, 2024
Insights
Insights
Reg impact assessment next in GenAI’s sights, experts claim
June 26, 2025
Insights
The now-urgent automation agenda: out-of-control regulatory workloads necessitate AI adoption
December 1, 2024
Insights
Improving life science R&D outcomes with AI
November 8, 2024
Insights
The medical device sector’s surging regulatory burden: how are suppliers coping?
October 12, 2024
Podcast
Awards
Rising Stars Award 2025 Nominations
Winners of LSV Top Industry Leaders Award 2024
List of Winners of the Rising Stars Award 2024
More
Manufacturing
Regulatory
Editorial
type here...
Search
Facebook
Linkedin
Twitter
Latest news
Commercial
July 11, 2025
AstraZeneca’s Alexion Signs $825 Million Gene Therapy Licensing Deal with JCR Pharmaceuticals
AstraZeneca’s rare disease division, Alexion, has finalized a license agreement with JCR Pharmaceuticals valued at up to $825 million....
Newsletter
July 7, 2025
Life Sciences Voice Top Five Newsletter
Welcome to this week’s edition of the Life Sciences Voice Top Five Newsletter, your go-to source for the latest...
Clinical
July 7, 2025
4DMT Accelerates Phase 3 Eye Gene Therapy Trials Despite 25% Workforce Reduction
4D Molecular Therapeutics (4DMT) is pressing ahead with its late-stage gene therapy ambitions even as it undergoes significant internal...
Regulatory
July 7, 2025
FDA Grants Accelerated Approval to Regeneron’s Lynozyfic for Advanced Multiple Myeloma
The U.S. Food and Drug Administration (FDA) has granted accelerated approval to Regeneron’s bispecific antibody linvoseltamab, now branded as...
Clinical
July 7, 2025
Bezuclastinib Meets Primary Endpoint in Phase 3 Trial for Systemic Mastocytosis
Cogent Biosciences has announced that its Phase 3 trial...
Clinical
July 4, 2025
Cosentyx Misses Primary Endpoint in Phase III Giant Cell Arteritis Trial
Novartis has reported that its anti-inflammatory drug Cosentyx did...
Manufacturing
July 4, 2025
Sandoz Begins Construction on $440M Biosimilar Facility in Slovenia as Part of $1.1B Investment Drive
Sandoz has broken ground on a new $440 million biosimilar manufacturing facility in Brnik, Slovenia, as part of a...
Clinical
July 4, 2025
Organon Says Goodbye to Endometriosis Drug Candidate After Phase 2 Failure
An Organon medication candidate, regarded as its most significant prospective chance, has failed a phase 2 study, leading the...
Commercial
July 4, 2025
Shionogi Acquires Rights to BioVersys’ BV500 Program Targeting NTM Infections
Shionogi & Co. has entered into a new agreement with Swiss biotech BioVersys to acquire rights to its preclinical...
Clinical
July 2, 2025
Atai–Beckley Merger Moves Forward After Psychedelic Nasal Spray Shows Promise in Depression Trial
Following promising Phase 2b results, Atai Life Sciences has...
Commercial
July 2, 2025
Argenx and Unnatural Products Sign $1.5 Billion Deal to Develop Macrocyclic Peptide Therapies
Argenx has entered into an agreement with California-based Unnatural...
Commercial
July 2, 2025
BerGenBio and Oncoinvent to Merge Amidst Former’s Cancer Drug Failure
BerGenBio, impacted by the unsuccessful outcome of its primary oncology medication, has chosen to merge with the Norwegian biotechnology...
Commercial
July 1, 2025
Xoma Acquires Turnstone Biologics in $8M Deal Amid Industry Struggles
Xoma Royalty acquires struggling San Diego biotech Turnstone Biologics for $7.9M after halted trials and layoffs. Explore the details...
Manufacturing
July 1, 2025
Sage Therapeutics to Lay Off All 338 Employees Following Supernus Acquisition
Sage Therapeutics will lay off all 338 employees following its $561M acquisition by Supernus. Discover how the deal, centered...
Commercial
AstraZeneca’s Alexion Signs $825 Million Gene Therapy Licensing Deal with JCR Pharmaceuticals
AstraZeneca’s rare disease division, Alexion, has finalized a license...
Editorial Team
-
Commercial
AmerisourceBergen Sheds Its Decades-Old Identity to Emerge as Cencora
AmerisourceBergen, the pharmaceutical manufacturing and services firm, has retired...
Commercial
Roche to lay off 300 to 400 employees in product development jobs
Roche’s executives, including CMO (Chief Medical Officer) Levi Garraway, claimed in a recorded video conference with staff acquired by Swiss Newspaper Blick
Popular
Most popular life news you must read today
View all articles
Insights
Parkinson’s, autism spectrum disorder, and the gut-brain axis: A role for psychobiotics in ameliorating neurological symptoms from the gut
June 2, 2022
Insights
A Patient Centric Approach to Clinical Research is Key for Product Development
February 22, 2023
Clinical
NRx Pharma’s ZYESAMI™ approved for emergency use Covid critical care in Georgia
August 3, 2021
Commercial
AstraZeneca’s Alexion Signs $825 Million Gene Therapy Licensing Deal with JCR Pharmaceuticals
Editorial Team
-
July 11, 2025
Shionogi Acquires Rights to BioVersys’ BV500 Program Targeting NTM Infections
Editorial Team
-
July 4, 2025
Argenx and Unnatural Products Sign $1.5 Billion Deal to Develop Macrocyclic Peptide Therapies
Editorial Team
-
July 2, 2025
BerGenBio and Oncoinvent to Merge Amidst Former’s Cancer Drug Failure
Editorial Team
-
July 2, 2025
Xoma Acquires Turnstone Biologics in $8M Deal Amid Industry Struggles
Editorial Team
-
July 1, 2025
Hummingbird Leverages VISTA Buzz to Land $290M Deal for Phase 2-Ready Cancer Drug
Editorial Team
-
June 28, 2025
Information Technology
Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI
Chugai Pharmaceutical has entered into a research collaboration with Singapore-based Gero to develop antibody-based...
Editorial Team
-
July 7, 2025
J&J MedTech presents the first Ottava surgical robot clinical cases
Johnson & Johnson MedTech successfully conducted the initial clinical use of Ottava surgical robot...
Editorial Team
-
April 17, 2025
Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances
Common conditions in women such as PCOS, menopause, and endometriosis often lead to hormonal...
Editorial Team
-
October 23, 2024
PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm
Health technology company PicnicHealth has launched a new product, Virtual Site, which allows researchers...
Editorial Team
-
September 26, 2024
Regulatory
Regulatory
FDA Grants Accelerated Approval to Regeneron’s Lynozyfic for Advanced Multiple Myeloma
The U.S. Food and Drug Administration (FDA) has granted...
Editorial Team
-
Newsletter
Life Sciences Voice Top Five Newsletter
Welcome to this week’s edition of the Life Sciences...
Clinical
4DMT Accelerates Phase 3 Eye Gene Therapy Trials Despite 25% Workforce Reduction
4D Molecular Therapeutics (4DMT) is pressing ahead with its...
Regulatory
FDA Grants Accelerated Approval to Regeneron’s Lynozyfic for Advanced Multiple Myeloma
The U.S. Food and Drug Administration (FDA) has granted...
Technology
Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI
Chugai Pharmaceutical has entered into a research collaboration with...
Research & Development
Scientists Identify New Target to Prevent Cancer from Spreading to Bones
May 22, 2025
New Data Positions Immutep’s Immunotherapy Combo as First-Line Option for PD-L1-Negative HNSCC
May 7, 2025
BioMed X Launches XBridge Program to Support U.S. Reacsearchers Amid NIH Funding Cuts
April 8, 2025
Taiho spends $400 million with a Swiss partner to “turbocharge” three ADCs to the clinic
March 20, 2025
Market Access
Sandoz Begins Construction on $440M Biosimilar Facility in Slovenia as Part of $1.1B Investment Drive
July 4, 2025
Sage Therapeutics to Lay Off All 338 Employees Following Supernus Acquisition
July 1, 2025
BioNTech to Cease Cell Therapy Manufacturing at Gaithersburg Site Following CAR-T Trial Setback
June 19, 2025
Roche offers $50 billion to US pharma production in response to the tariff threat
April 24, 2025
Manufacturing
June 8, 2024
French Company Orano Med Opens New Radiation Production Facility Near Indianapolis
In a nuclear medicine surge, industry leader Orano Med...
Manufacturing
May 28, 2024
Gerresheimer Increases the Capabilities of Medical Systems in the USA
Gerresheimer, the maker of innovative systems and solutions and...
Manufacturing & Regulatory
POPULAR
Find Your Perfect Music Festival
Commercial
AstraZeneca’s Alexion Signs $825 Million Gene Therapy Licensing Deal with JCR Pharmaceuticals
AstraZeneca’s rare disease division, Alexion, has finalized a license...
Editorial Team
-
Manufacturing
Sage Therapeutics to Lay Off All 338 Employees Following Supernus Acquisition
Sage Therapeutics will lay off all 338 employees following...
Editorial Team
-
Clinical
4DMT Accelerates Phase 3 Eye Gene Therapy Trials Despite 25% Workforce Reduction
4D Molecular Therapeutics (4DMT) is pressing ahead with its...
Editorial Team
-